Keyphrases
Adjuvant Radiotherapy
19%
Advanced Ovarian Cancer
38%
Advanced Stage
20%
Cancer Stage
30%
Cervical Cancer
84%
Cervical Cancer Patients
34%
Cervical Carcinoma
28%
Cesarean Section (C-section)
19%
Chemotherapy
34%
Chromosome Breakage
28%
Curcumin
28%
Developing Countries
25%
Endometriosis
30%
Enlargement
13%
Epithelial Ovarian Cancer
13%
Epithelial Phenotype
17%
Group-based
19%
High-risk Human Papillomavirus (HR-HPV)
19%
Histopathological Examination
15%
Ifosfamide
16%
Indonesia
54%
Intermediate-risk Group
19%
Invasive Cervical Cancer
21%
Jakarta
70%
Laparoscopy
28%
Magnetic Resonance Imaging
14%
Malignancy
16%
Metastasis
28%
Micronucleus
20%
Mucinous
14%
Nanocurcumin
28%
NF-B
13%
Nodule
18%
Older Women
17%
Ovarian Cancer
28%
Placenta Accreta
19%
Prognostic Factors
23%
Radical Surgery
19%
Rare Case Report
47%
Recurrence-free Survival
19%
Squamous Cell Carcinoma (SqCC)
20%
Stage IA2
14%
Stage IB
30%
Sulawesi Propolis
19%
Survival Rate
31%
Survival Stage
19%
Total Hysterectomy
19%
Tumor
13%
Tumor Size
24%
Visual Inspection with Acetic Acid
31%
Medicine and Dentistry
Abdominal Wall
14%
Acetic Acid
44%
Biopsy Technique
18%
Bleeding
14%
CA-125
24%
Cancer
14%
Cancer Staging
26%
Cervical Cancer
100%
Cervical Cancer Prevention
11%
Cervical Cancer Screening
11%
Cesarean Section
18%
Chromosome Breakage
28%
Cryotherapy
12%
Cytoreductive Surgery
23%
Debulking Surgery
19%
Diseases
11%
Echography
16%
Endometriosis
23%
Endometrium
11%
Gestational Age
11%
Gynecology
10%
Health System
9%
Histopathology
46%
Hysterectomy
20%
Krukenberg Tumor
28%
Laparoscopic Surgery
28%
Lymph Duct
10%
Lymph Node Metastasis
13%
Lymphocyte
19%
Magnetic Resonance Imaging
13%
Malathion
19%
Malignant Neoplasm
23%
Metastatic Carcinoma
52%
Micronucleus
20%
Micronucleus Test
12%
Neoadjuvant Chemotherapy
11%
Neoplasm
42%
Obstetrics
11%
Ovarian Cancer
48%
Patient Referral
16%
Pelvis
15%
Precancerous Condition
15%
Prevalence
19%
Prognostic Factor
12%
Recurrent Disease
13%
Retrospective Study
15%
Squamous Cell Carcinoma
22%
Survival Rate
28%
Uterine Cervix Carcinoma
19%
Uterine Perforation
11%